Sector
PharmaceuticalsOpen
₹834.55Prev. Close
₹825.45Turnover(Lac.)
₹183.94Day's High
₹860Day's Low
₹820.552 Week's High
₹1,07852 Week's Low
₹440.1Book Value
₹70.44Face Value
₹10Mkt Cap (₹ Cr.)
2,279.9P/E
362.04EPS
2.28Divi. Yield
0.12Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 25.85 | 25.16 | 25.16 | 24.56 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 95.93 | 69.3 | 66.21 | 41.81 |
Net Worth | 121.78 | 94.46 | 91.37 | 66.37 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 106.84 | 95.08 | 85.62 | 77.84 |
yoy growth (%) | 12.36 | 11.03 | 10 | 8.75 |
Raw materials | -73.34 | -66.3 | -57.01 | -51.03 |
As % of sales | 68.64 | 69.72 | 66.58 | 65.56 |
Employee costs | -9.3 | -10.34 | -8.89 | -6.63 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | -1.34 | 3.88 | 7.85 | 11.36 |
Depreciation | -3.16 | -2.09 | -1.39 | -0.93 |
Tax paid | 0.15 | -1.12 | -2.3 | -4.07 |
Working capital | 2.77 | -2.38 | 8.18 | 12.04 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 12.36 | 11.03 | 10 | 8.75 |
Op profit growth | -85.09 | -41.46 | -28.94 | 8.56 |
EBIT growth | -131.25 | -49.98 | -31.23 | 26.97 |
Net profit growth | -105.88 | -50.28 | -23.6 | 31.15 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 180.49 | 139.96 | 131.19 | 106.79 | 95.11 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 180.49 | 139.96 | 131.19 | 106.79 | 95.11 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.16 | 2.49 | 1.63 | 2.29 | 1.51 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,614 | 122.93 | 3,87,276.66 | 1,181.05 | 0.84 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,568.7 | 71.3 | 1,47,802.29 | 594 | 0.54 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,461.75 | 25.37 | 1,18,061.19 | 1,438.15 | 0.89 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,059 | 56.75 | 1,03,513.97 | 485 | 0.92 | 2,330 | 222.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,140.1 | 18.33 | 95,026.5 | 849.4 | 0.7 | 4,997.8 | 322.46 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Ketankumar Zota
Managing Director
Moxesh Zota
Whole-time Director
Kamlesh Zota
Whole-time Director
Himanshu Zota
Whole-time Director
Manukant Zota
Independent Director
Varsaben Mehta
Company Secretary
Ashvin Variya
Addtnl Independent Director
Bhumi Maulik Doshi
Independent Director
Dhiren Prafulbhai Shah
Independent Director
Jayshreeben N Mehta
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Zota Health Care Ltd
Summary
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products. The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat. The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving Indias pharmaceutical industry a boost.The Company has three business verticals: Marketing-a traditional business vertical, and driving business verticals - Exports and Retail harmacy Chain. Through its chain, Davaindia, the largest private-sector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business. The Companys state-of-the-art manufacturing facility at Sachin SEZ serves customers in more than 30 countries. Davaindia is a retail generic pharmacy chain whose core value proposition is providing quality generic medicines at substantial discounts, i.e. 30% to 90%, to their branded equivalents. Davaindia focuses on private-label products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments.The Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Companys distribution network across India. In domestic Marketing business, the Compa
Read More
The Zota Health Care Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹831.85 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zota Health Care Ltd is ₹2279.90 Cr. as of 06 Mar ‘25
The PE and PB ratios of Zota Health Care Ltd is 362.04 and 10.30 as of 06 Mar ‘25
The 52-week high/low is the highest and lowest price at which a Zota Health Care Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Zota Health Care Ltd is ₹440.1 and ₹1078 as of 06 Mar ‘25
Zota Health Care Ltd's CAGR for 5 Years at 38.14%, 3 Years at 40.77%, 1 Year at 66.10%, 6 Month at 23.36%, 3 Month at 36.40% and 1 Month at -17.04%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.